Understanding the Role of Ozempic Ozempic, a semaglutide-based medication, plays a crucial role in managing type 2 diabetes by lowering blood sugar levels
It fights harmful things like toxins and free radicals
Maya Shankar: How to Shape Your Identity & Goals In this episode, my guest is Maya Shankar, Ph.D., a cognitive scientist, former senior advisor to the White House and Chair of the White House Social and Behavioral Sciences Team
Conclusion Four completed trials now confirm retatrutide's efficacy across different populations, doses, and durations: Phase 2 (338 patients, 48 weeks): 24.2% proof of concept TRIUMPH-4 (445 patients, 68 weeks): 28.7% first Phase 3 confirmation TRIUMPH-1 (2,339 patients, 80 weeks): 28.3% pivotal confirmation in general obesity population TRIUMPH-1 extension (subset, 104 weeks): 30.3% weight loss continues beyond 80 weeks TRANSCEND-T2D-1 (537 patients, 40 weeks): 16.8% weight loss and -2.0% HbA1c in type 2 diabetes The consistency between TRIUMPH-4 (28.7%) and TRIUMPH-1 (28.3%) across two very different populations is the most important finding for obesity it means the results aren't driven by population-specific factors, they reflect the drug's fundamental mechanism
Bempedoic acid and ezetimibe better together
